AVITA Medical, Inc. Appoints Cary Vance as President and CEO

AVITA Medical, Inc. announced the appointment of Cary Vance as President and Chief Executive Officer, effective April 30, 2026. Vance, who has been with the company since April 2023 and served as Interim CEO and Executive Chairman since October 2025, will continue to serve on the Board. Jan Stern Reed has been appointed Chair of the Board. Vance brings extensive leadership experience in the healthcare industry, having held executive positions at several medical technology companies. His employment agreement includes an annual base salary of $702,000, eligibility for an annual bonus, and significant equity grants (RSUs and stock options) subject to stockholder approval. The agreement also outlines terms for termination, severance benefits, and continued participation in employee benefit plans. The company also issued a press release on April 30, 2026, detailing these appointments.